---
title: "New Era Alkaloids And Export (530303) Financials & Shareholding"
symbol: "530303"
company: "New Era Alkaloids And Export Ltd"
canonical: "https://tapetide.com/stocks/530303"
bse_code: "530303"
generated_at: "2026-11-05T01:45:17.888Z"
---

# New Era Alkaloids And Export (530303)

Canonical page: https://tapetide.com/stocks/530303

## Key Facts

- **Revenue, Jun 2026 quarter:** under ₹0.01 Cr, against ₹0.25 Cr in Jun 2025
- **Net profit, Jun 2026 quarter:** -₹0.02 Cr, against under ₹0.01 Cr in Jun 2025

## Company

- **BSE code:** 530303
- **In the F&O segment:** No

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rate

Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure.

| Metric | Window | Growth | What it compares |
| --- | --- | ---: | --- |
| Revenue | 10Y | 15.87% | compounded annual rate, Mar 2016 to Mar 2026 |
| Revenue | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. |
| Revenue | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. |
| Revenue | 1Y | -51.52% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Revenue | TTM | -75.53% | four quarters to Jun 2026 vs the four to Jun 2025 |
| Net profit | 10Y | Turned to loss | compounded annual rate, Mar 2016 to Mar 2026: ₹0.08 Cr to -₹0.23 Cr. A profit at the start and a loss at the end. |
| Net profit | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. |
| Net profit | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. |
| Net profit | 1Y | Loss widened | fiscal year to Mar 2026 vs the year to Mar 2025: -₹0.02 Cr to -₹0.23 Cr. A loss at both ends, larger at the end. |
| Net profit | TTM | Loss widened | four quarters to Jun 2026 vs the four to Jun 2025: -₹0.01 Cr to -₹0.25 Cr. A loss at both ends, larger at the end. |
| Operating margin | 10Y | -5.49 pp | compounded annual rate, Mar 2016 to Mar 2026 |
| Operating margin | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. |
| Operating margin | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. |
| Operating margin | 1Y | -12.56 pp | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Operating margin | TTM | -38.07 pp | four quarters to Jun 2026 vs the four to Jun 2025 |

## Financial Statements

### Quarterly Results

Figures in ₹ crore unless the row name gives another unit.

| Item | Jun 2021 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0.44 | 0.25 | 0.25 | 0 | 0 | 0.23 | 0 |
| Expenses | 0.03 | 0.01 | 0.01 | 0.02 | 0.3 | 0.04 | 0.4 | 0.26 | 0.25 | 0.03 | 0.02 | 0.25 | 0.02 |
| Operating Profit | -0.03 | -0.01 | -0.01 | -0.02 | -0.3 | -0.04 | 0.04 | -0.01 | 0 | -0.03 | -0.02 | -0.02 | -0.02 |
| OPM % | — | — | — | — | — | — | 9.09% | -4% | 0% | — | — | -8.7% | — |
| Other Income | 0.05 | 0.06 | 0.16 | 0.07 | 0.3 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0.08 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.02 | 0.05 | 0.15 | 0.05 | 0 | -0.04 | 0.04 | 0.06 | 0 | -0.03 | -0.02 | 0.06 | -0.02 |
| Tax % | -150% | 0% | 0% | 0% | — | 0% | 175% | 0% | — | 0% | 0% | 400% | 0% |
| Net Profit | 0.05 | 0.05 | 0.15 | 0.05 | 0 | -0.04 | -0.03 | 0.06 | 0 | -0.03 | -0.02 | -0.18 | -0.02 |

### Profit & Loss

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 1.16 | 0.28 | 0.11 | 0.04 | 1.83 | 1.08 | 0 | 0.99 | 0.48 | 0.23 |
| Expenses | 0.91 | 0.42 | 0.12 | 0.18 | 1.71 | 0.86 | 0.06 | 1.01 | 0.55 | 0.32 |
| Operating Profit | 0.25 | -0.14 | -0.01 | -0.14 | 0.12 | 0.22 | -0.06 | -0.02 | -0.07 | -0.09 |
| OPM % | 21.55% | -50% | -9.09% | -350% | 6.56% | 20.37% | — | -2.02% | -14.58% | -39.13% |
| Other Income | 0.09 | 0.01 | 0.09 | 0.06 | 0 | 0.38 | 0.39 | 0.07 | 0.08 | 0.08 |
| Interest | 0.03 | 0 | 0.01 | 0.05 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| Depreciation | 0.13 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.18 | -0.26 | 0.07 | -0.13 | 0.12 | 0.59 | 0.33 | 0.05 | 0.01 | -0.01 |
| Tax % | 0% | -11.54% | -28.57% | 61.54% | 16.67% | 25.42% | 0% | 140% | 2,400% | — |
| Net Profit | 0.18 | -0.23 | 0.08 | -0.21 | 0.09 | 0.43 | 0.33 | -0.02 | -0.23 | -0.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |

### Balance Sheet

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2024 | Mar 2025 | Sep 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Equity Capital | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 |
| Reserves | 1.32 | 1.22 | 1.29 | 1.08 | 0.7 | 2.76 | 4.74 | 4.9 | 4.87 |
| Borrowings | 9.81 | 7.57 | 23.53 | 24.16 | 23.81 | 0.6 | 0 | 1.8 | 1.1 |
| Other Liabilities | 16.29 | 15.39 | 3.19 | 0.53 | 0.68 | 14.7 | 0.61 | 0.29 | 0.02 |
| Total Liabilities | 30.7 | 27.46 | 31.29 | 29.05 | 28.47 | 21.34 | 8.63 | 10.27 | 9.27 |
| Fixed Assets | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5.36 | 8.41 | 8.41 | 8.41 | 6.04 | 7.66 | 2.13 | 2.42 | 2.31 |
| Other Assets | 25.26 | 18.97 | 22.81 | 20.57 | 22.36 | 13.62 | 6.5 | 7.85 | 6.96 |
| Total Assets | 30.7 | 27.46 | 31.29 | 29.05 | 28.47 | 21.34 | 8.63 | 10.27 | 9.27 |

### Cash Flow

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash from Operating Activity | — | 1.26 | 0.52 | 0 | -2.67 | 9.05 | -0.76 | -1.75 | — |
| Cash from Investing Activity | — | 0.97 | -2.9 | 0 | 1.85 | 0 | 8.66 | 0 | — |
| Cash from Financing Activity | — | -2.26 | 2.43 | 0 | -0.36 | -9.09 | -7.89 | 1.87 | — |
| Net Cash Flow | — | -0.02 | 0.05 | 0 | -1.18 | -0.04 | 0.01 | 0.11 | — |
| Free Cash Flow | — | 1.26 | 0.52 | 0 | -2.67 | 9.05 | -0.76 | -1.75 | — |
| CFO/OP | — | -900 | -5,200 | 0 | -2,208 | 4,182 | 283 | 8,400 | — |

### Ratios

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Debtor Days | 909 | 1,147 | 2,455 | 0 | 269 | 0 | — | 55.3 | — |
| Inventory Days | 223 | 0 | — | — | — | — | — | 0 | — |
| Days Payable | 6,540 | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | -5,407 | 1,147 | 2,455 | 0 | 269 | 0 | — | 55.3 | — |
| Working Capital Days | -4,056 | n/m | 2,688 | 1,369 | 1,388 | -4,106 | — | 107 | — |
| ROCE % | — | -1.96% | 0.4% | -0.28% | 0.43% | 3.49% | — | 0.56% | — |

n/m: Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.

## Shareholding Pattern

Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

## Frequently Asked Questions about New Era Alkaloids And Export

### Where is New Era Alkaloids And Export Ltd (530303) listed?

New Era Alkaloids And Export Ltd trades under code 530303 on the BSE.

## Company Information

- **Face Value:** ₹10

---

Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time.

Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text.

For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Generated 5 Nov 2026, 07:15 IST.